This study investigates eltronmobag as an alternative treatment pathway, which depend on stimulation of thrombocyte synthesis, in chronic and persistent immune thrombocytopenia that may be a more promising treatment than the classic type, not only by increasing platelets count but also through enhancing of the platelets activation and up regulation of GPVI expression on platelet surface.

Egypt

https://clinicaltrials.gov/ct2/show/NCT03412188?recrs=a&cond=ITP&draw=1&rank=13

Recruiting